{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:38:46Z","timestamp":1792741126789,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009749","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000}}],"reference-count":84,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009749.pub2","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T12:27:07Z","timestamp":1448540827000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction"],"prefix":"10.1002","volume":"2015","author":[{"given":"Helen E","family":"Nagels","sequence":"first","affiliation":[{"name":"University of Auckland; Obstetrics and Gynaecology; FMHS Park Road Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine R","family":"Rishworth","sequence":"additional","affiliation":[{"name":"University of Auckland; Obstetrics and Gynaecology; FMHS Park Road Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos S","family":"Siristatidis","sequence":"additional","affiliation":[{"name":"University of Athens; Assisted Reproduction Unit, 3rd Department of Obstetrics and Gynaecology; Attikon University Hospital, Rimini 1 Athens Chaidari Greece 12462"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Kroon","sequence":"additional","affiliation":[{"name":"Queensland Fertility Group Research Foundation; 55 Little Edward St, Level 2 Boundary Court Spring Hill Brisbane Queensland Australia 4000"},{"name":"The University of Queensland; Obstetrics & Gynaecology; Brisbane Queensland Australia 4072"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD009749.pub2-BIB0001|cit1","first-page":"669-73","article-title":"DHEA supplementation improves follicular microenvironment in poor responder patients","volume":"28","author":"Artini","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0015-0282(03)02094-6","article-title":"Does dehidroepiandrosterone sulfate (Dheas) co-treatment improve art outcome? A prospective, randomized, double-blind placebo-controlled trial","volume":"80 Suppl 3","author":"Divita","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0003|cit3","unstructured":"Evans J A randomised, double blinded, placebo controlled, single centre trial comparing dehydroepiandrosterone (DHEA) and placebo in the treatment of women with resistant ovaries prior to in vitro fertilisation (IVF) and intra cytoplasmic sperm injection (ICSI). RCOG World Congress; 2013 June 24-26; Liverpool, UK BJOG 2013 225"},{"issue":"2","key":"10.1002\/14651858.CD009749.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/humrep\/den428","article-title":"Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial","volume":"24","author":"F\u00e1bregues","year":"2009","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0005|cit5","unstructured":"Jindal A Singh R A prospective randomised controlled study on the role of dehydroepiandrosterone (DHEA) on improving ovarian response in known poor responders in previous failed IVF-ICSI cycles Human Reproduction 2014 Supp 1, i14"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2013.11.008","article-title":"Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?","volume":"173","author":"Kara","year":"2014","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3, Supplement","key":"10.1002\/14651858.CD009749.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S518","DOI":"10.1016\/j.fertnstert.2013.07.246","article-title":"Is dehydroepiandrosterone (DHEA) supplementation really effective on IVF-ICSI outcome in patients with poor ovarian reserve?","volume":"100","author":"Kara","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD009749.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.fertnstert.2010.07.622","article-title":"Ovarian features after 2 weeks, 3 weeks and 4 weeks transdermal testosterone gel treatment and their associated effect on IVF\/ICSI outcome in low responders","volume":"94","author":"Kim","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD009749.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","article-title":"The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders","volume":"95","author":"Kim","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0010|cit10","unstructured":"D\u00edaz C Pellicer A Marzal A Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders (FOLLPRIM) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01310647"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0011|cit11","unstructured":"D\u00edaz C Pellicer A Marzal A Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders (FOLLPRIM) personal correspondence 2014"},{"issue":"Supp 1","key":"10.1002\/14651858.CD009749.pub2-BIB0012|cit12","first-page":"i25","article-title":"Antral follicle priming prior to ICSI in confirmed low responders: a randomized clinical trial (FOLLPRIM)","volume":"29","author":"Marzal","year":"2014","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD009749.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/humrep\/dei481","article-title":"Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study","volume":"21","author":"Massin","year":"2006","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD009749.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"268-74","DOI":"10.1016\/j.mefs.2012.11.002","article-title":"Long-term androgen priming by use of dehydroepiandrosterone (DHEA) improves IVF outcome in poor-responder patients. A randomized controlled study","volume":"17","author":"Moawad","year":"2012","journal-title":"Middle East Fertility Society Journal"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0015|cit15","first-page":"7","article-title":"Potential benefit of dehydroepiandrosterone supplementation for infertile but not poor responder patients in a IVF program","volume":"67","author":"Tartagni","year":"2015","journal-title":"Minerva Ginecologica"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12958-015-0014-3","article-title":"Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old","volume":"13","author":"Tartagni","year":"2015","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"10","key":"10.1002\/14651858.CD009749.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/deq220","article-title":"Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study","volume":"25","author":"Wiser","year":"2010","journal-title":"Human Reproduction"},{"issue":"3, Supplement","key":"10.1002\/14651858.CD009749.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.fertnstert.2013.07.1658","article-title":"A randomized double-blinded placebo-controlled trial on the effect of 16 weeks of dehydroepiandrosterone (DHEA) on ovarian reserve markers and IVF outcomes in normal responders","volume":"100","author":"Yeung","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"3, Suppl","key":"10.1002\/14651858.CD009749.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.fertnstert.2013.07.1521","article-title":"A randomized double-blinded placebo-controlled trial on the effect of 16 weeks of dehydroepiandrosterone (DHEA) on ovarian reserve markers and IVF outcomes in poor responders","volume":"100","author":"Yeung","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","article-title":"A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders","volume":"102","author":"Yeung","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13048-014-0093-3","article-title":"Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial","volume":"7","author":"Zhang","year":"2014","journal-title":"Journal of Ovarian Research"},{"issue":"7","key":"10.1002\/14651858.CD009749.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/humrep\/del052","article-title":"Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH","volume":"21","author":"Balasch","year":"2006","journal-title":"Human Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD009749.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/humrep\/del254","article-title":"Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF","volume":"21","author":"Barad","year":"2006","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1002\/14651858.CD009749.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"629-34","DOI":"10.1007\/s10815-007-9178-x","article-title":"Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function","volume":"24","author":"Barad","year":"2007","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0025|cit25","unstructured":"Barad D A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00419913"},{"issue":"10","key":"10.1002\/14651858.CD009749.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/humrep\/15.10.2129","article-title":"Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series","volume":"15","author":"Casson","year":"2000","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/humrep\/des349","article-title":"The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: is it hypoandrogenic?","volume":"28","author":"Santos","year":"2013","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0028|cit28","unstructured":"F\u00e1bregues F Efficacy of Luteinizing Hormone (LH) Activity in Low Responder Patients With Transdermal Testosterone https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01291212"},{"issue":"10","key":"10.1002\/14651858.CD009749.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"940-3","DOI":"10.3109\/09513590.2013.819087","article-title":"DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function","volume":"29","author":"Fusi","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10815-012-9890-z","article-title":"Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR)","volume":"30","author":"Gleicher","year":"2013","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"4, Supplement","key":"10.1002\/14651858.CD009749.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.fertnstert.2010.07.330","article-title":"Dehydroepiandrosterone (DHEA) supplementation for poor responders - how does it work?","volume":"94","author":"Hyman","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"49-53","DOI":"10.1016\/j.ejogrb.2012.12.017","article-title":"DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism","volume":"168","author":"Hyman","year":"2013","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009749.pub2-BIB0033|cit33","first-page":"i342","article-title":"Molecular expression of androgen and FSH receptors after follicular priming prior to ICSI cycles - an interim analysis of the IFILL-PRIMI randomised controlled trial","volume":"28","author":"Monterde","year":"2013","journal-title":"Human Reproduction"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009749.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1016\/j.fertnstert.2006.07.1183","article-title":"The use of DHEA in poor responders does not improve IVF outcomes: insights of a pilot study","volume":"86","author":"Motta","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD009749.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"989-92","DOI":"10.3109\/09513590.2013.824957","article-title":"A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve","volume":"29","author":"Singh","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD009749.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/humrep\/dep442","article-title":"Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles","volume":"25","author":"Sipe","year":"2010","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD009749.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.rbmo.2009.06.006","article-title":"Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders","volume":"19","author":"S\u00f6nmezer","year":"2009","journal-title":"Reproductive BioMedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"380-8","DOI":"10.1210\/jc.2012-3071","article-title":"A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency","volume":"98","author":"Yeung","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0039|cit39","unstructured":"Study of Oral Dehydroepiandrosterone (DHEA) to Treat Previously Unexplained Infertility Ongoing study March 2008"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0040|cit40","unstructured":"A Randomized Double Blind Control Trial of Transdermal\u00a0Testosterone Supplementation vs Placebo on Follicular Development and Atresia, Oocyte and Embryo Quality Among Women With Diminished Ovarian Reserve Undergoing\u00a0in Vitro Fertilization Ongoing study"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bmjopen-2014-005767","article-title":"Efficacy of dehydroepiandrosterone to overcome the effect of ovarian ageing (DITTO): A proof of principle randomised controlled trial protocol","volume":"4","author":"Jayaprakasan","year":"2014","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0042|cit42","unstructured":"Transdermal\u00a0Testosterone\u00a0Pretreatment in Poor Responders Undergoing\u00a0IVF Ongoing study"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0043|cit43","unstructured":"DHEA\u00a0Supplementation for Low Ovarian Response\u00a0IVF\u00a0Patients Ongoing study Jan 2008"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0044|cit44","unstructured":"Study of\u00a0Dehydroepiandrosterone\u00a0Treatment for Poor Responders in\u00a0In Vitro Fertilization\u00a0Patients Ongoing study February 2012"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0045|cit45","unstructured":"Prospective Randomized Trial on the Effect of\u00a0DHEA Administration in Women With Poor Ovarian Reserve Undergoing Controlled Ovarian Stimulation for\u00a0IVF. Impact on Stimulation Characteristics and Pregnancy Outcome. Ongoing study April 2014"},{"issue":"8","key":"10.1002\/14651858.CD009749.pub2-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009452.pub2","article-title":"Heparin for assisted reproduction","author":"Akhtar","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009749.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/humupd\/dmr051","article-title":"The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis","volume":"18","author":"Bosdou","year":"2012","journal-title":"Human Reproduction Update"},{"issue":"5","key":"10.1002\/14651858.CD009749.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00345-003-0367-7","article-title":"Androgen therapy with dehydroepiandrosterone","volume":"21","author":"Buvat","year":"2003","journal-title":"World Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0015-0282(98)00121-6","article-title":"Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial","volume":"70","author":"Casson","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD009749.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006920.pub3","article-title":"Acupuncture and assisted reproductive technology","author":"Cheong","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009749.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Schulz","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD009749.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"Journal of Clincal Endocrinology and Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD009749.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1239-44","DOI":"10.1007\/s10815-013-0018-x","article-title":"Is there a role for DHEA supplementation in women with diminished ovarian reserve?","volume":"30","author":"Fouany","year":"2013","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"6","key":"10.1002\/14651858.CD009749.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.fertnstert.2003.11.032","article-title":"Effect of androgen levels on in vitro fertilization cycles","volume":"81","author":"Frattarelli","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD009749.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0015-0282(01)01902-1","article-title":"Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women","volume":"76","author":"Genazzani","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1477-7827-7-108","article-title":"Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study","volume":"7","author":"Gleicher","year":"2009","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/CBO9780511894756.017","article-title":"Dehydroepiandrosterone","volume-title":"How to improve your ART success rates","author":"Gleicher","year":"2011"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1477-7827-9-116","article-title":"The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD009749.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/humrep\/deh870","article-title":"Definition and prevalence of subfertility and infertility","volume":"20","author":"Gnoth","year":"2005","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD009749.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"450-9","DOI":"10.1016\/j.rbmo.2012.07.011","article-title":"Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis","volume":"25","author":"Gonz\u00e1lez-Comadran","year":"2012","journal-title":"Reproductive BioMedicine Online"},{"issue":"7414","key":"10.1002\/14651858.CD009749.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0063|cit63","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD009749.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/oxfordjournals.humrep.a137595","article-title":"Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium","volume":"7","author":"Horie","year":"1992","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD009749.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"931.e1","DOI":"10.1016\/j.fertnstert.2008.08.115","article-title":"Onset of late posttraumatic seizure after dehydroepiandrosterone treatment","volume":"91","author":"Karp","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD009749.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.fertnstert.2007.11.055","article-title":"Premature ovarian failure and dehydroepiandrosterone","volume":"91","author":"Mamas","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD009749.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/GCO.0b013e32832e0785","article-title":"Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results","volume":"21","author":"Mamas","year":"2009","journal-title":"Current Opinion in Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD009749.pub2-BIB0068|cit68","first-page":"1360","article-title":"Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age","volume":"78","author":"Morales","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD009749.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Molecular Human Reproduction"},{"key":"10.1002\/14651858.CD009749.pub2-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"3","key":"10.1002\/14651858.CD009749.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jcem-28-3-355","article-title":"Steroid formation by isolated and recombined ovarian granulosa and thecal cells","volume":"28","author":"Ryan","year":"1968","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD009749.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1393-403","DOI":"10.1210\/me.2010-0006","article-title":"Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function","volume":"24","author":"Sen","year":"2010","journal-title":"Molecular Endocrinology"},{"issue":"10","key":"10.1002\/14651858.CD009749.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","article-title":"Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization","volume":"17","author":"Sir-Petermann","year":"2002","journal-title":"Human Reproduction"},{"issue":"8","key":"10.1002\/14651858.CD009749.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004832.pub3","article-title":"Aspirin for in vitro fertilisation","author":"Siristatidis","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009749.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004509.pub2","article-title":"Testosterone for peri- and postmenopausal women","author":"Somboonporn","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009749.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rbmo.2011.01.015","article-title":"Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis","volume":"22","author":"Sunkara","year":"2011","journal-title":"Reproductive BioMedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD009749.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0015-0282(02)04197-3","article-title":"Progress we can be proud of: U.S. trends in assisted reproduction over the first 20 years","volume":"78","author":"Toner","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD009749.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"353-7","DOI":"10.1095\/biolreprod61.2.353","article-title":"Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary","volume":"61","author":"Vendola","year":"1999","journal-title":"Biology of Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD009749.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.fertnstert.2011.07.214","article-title":"Improved probability of pregnancy with transdermal testosterone pretreatment in poor responders treated with GnRH analogues and gonadotrophins for in-vitro fertilization: a meta-analysis","volume":"96","author":"Venetis","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD009749.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jcem.83.7.4917","article-title":"Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations","volume":"83","author":"Weil","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD009749.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD009749.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1941-4","DOI":"10.1093\/humrep\/der150","article-title":"DHEA as a miracle drug in the treatment of poor responders; hype or hope?","volume":"26","author":"Yakin","year":"2011","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD009749.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.fertnstert.2009.09.009","article-title":"International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009","volume":"92","author":"Zegers-Hochschild","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD009749.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009749","article-title":"Androgens (dehydroepiandrosterone or testosterone) in women undergoing assisted reproduction","author":"Nagels","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009749.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009749.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T21:05:47Z","timestamp":1696799147000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009749.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":84,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009749.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD009749.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]}}}